SCHEMBL9637312

SCHEMBL9637312

CC1=C(C(=O)OC2CC2)N2C(=O)C[C@@H]2S(=O)(=O)C1

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ELANE P08246 6/20 0.43
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ESR1 P03372 1/20 0.32
ATM Q13315 1/20 0.30
HTR7 P34969 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9368293 0.82 ELANE (0.62) ELANE
SCHEMBL17830878 0.80 ELANE (0.40) ELANEMEN1KMT2AESR1
SCHEMBL8668630 0.78 ELANE (0.40) ELANEMEN1KMT2A
SCHEMBL7397916 0.73
SCHEMBL8371886 0.72 ELANE (0.52) ELANE
SCHEMBL4344464 0.65 ELANE (0.50) ELANE
SCHEMBL7324300 0.65 ELANE (0.37) ELANEMEN1KMT2AESR1
SCHEMBL7341895 0.65 ELANE (0.50) ELANE
SCHEMBL7301346 0.64 ELANE (0.34) ELANEMEN1KMT2AESR1
SCHEMBL7443895 0.64 ELANE (0.39) ELANEMEN1KMT2AESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991004977-A1 NOVEL 2-SPIROCYCLOPROPYL CEPHALOSPORIN SULFONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF SYNPHAR LABORATORIES, INC. (CA) 1991-04-18 WO claimed
EP-0494914-A1 NOVEL 2-SPIROCYCLOPROPYL CEPHALOSPORIN SULFONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF SYNPHAR LABORATORIES INC. (CA) 1992-07-22 EP disclosed
WO-1991004977-A1 NOVEL 2-SPIROCYCLOPROPYL CEPHALOSPORIN SULFONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF SYNPHAR LABORATORIES, INC. (CA) 1991-04-18 WO disclosed